Monday December 01 2008 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
  • A-Z

Central Nervous System Report 2002

In 2001 CNS therapies held a market share worth in excess on $40 billion

- the strongest growth of any therapeutic class with a staggering 17 per cent. In the US, drug therapies for CNS lead the pack where prescription drugs expenditure is concerned, with therapies holding a market size of more than $28 billion ($4 billion more than its closets competitor).

If you are not part of this market - you should be.

If you are part of this market then you need to increase your share.

This report tells you how to!

Is the answer the future pharmaceutical management of the most prominent CNS disorders in the exploitation of novel mechanisms which have previously eluded the R&D world, or is it in the intelligent use of those products which are currently available - and if so, what might the impact be on those companies involved?

CNS 2002 by visiongain provides the reader with up-to-date listings of the current pipelines for the leading companies engaged in the R&D into the treatment of CNS disorders, as well as detailed drug profiles of the therapies currently available and their application in the future treatment of prominent CNS disorders.

How you can benefit from this report?

-- Assess the performance of rapidly developing drugs in each therapy class

-- Discover the strength of companies' CNS through detailed analysis of products and R&D

-- Benchmark leading & developing products on the basis of key performance measures.

-- Understand the importance of novel therapeutics to sustained growth in this mature market.

Utilize independent, novel analytical frameworks to enhance your strategic decision making. This report is available CD Rom which is fully colour illustrated it makes it ideal for presentation use.

- PRICING -

Individual report pricing - single user copies of this report are available for only US$1595. Allow your whole company to have access to this information for only the price of 4 copies. Company-wide License (CD Rom and .pdf for company intranet use) for only US$6395.

Size: 150 pages

Format: CD ROM


View pdf brochure

To order - click here!

 

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright © 1997-2008 - BioPortfolio Limited.